Indicators

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

By: News Direct

October 21, 2022 at 11:00 AM EDT

--News Direct--

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

View original content to download multimedia: https://newsdirect.com/news/nasdaq-agrx-agile-therapeutics-anticipates-increased-growth-in-q3-of-2022-580154414

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.